Previous 10 | Next 10 |
Since the beginning of the year, the marijuana sector has underperformed dramatically. The effects of COVID-19, oversupply in Canada, and falling consumer spending are all leading investors to get out of weed stocks en masse , with little regard for long-term outlook. However, the market ha...
Delta, Kelowna, BC - August 7, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca release today's podcast edition of cannabis news and stocks to watch plus insight from...
Image source: The Motley Fool. Cronos Group Inc. (NASDAQ: CRON) Q2 2020 Earnings Call Aug 06, 2020 , 8:30 a.m. ET Operator Continue reading
Shares of Cronos Group (NASDAQ: CRON) sank 15.9% on Thursday, following the marijuana producer's disappointing second-quarter results. Cronos Group's net revenue climbed 29% year over year to $9.9 million. The gains were driven by the launch of cannabis vaporizers in Canada, as w...
Cronos Group (NASDAQ: CRON) had made great progress in recovering from the shellacking it took during the coronavirus-fueled market meltdown earlier this year. As of its close on Wednesday, Cronos stock was up more than 20% over the last three months. But that momentum has now fizzled. ...
Cronos Group Inc. (CRON) Q2 2020 Results Conference Call August 06, 2020 08:30 AM ET Company Participants Shayne Laidlaw - IR Mike Gorenstein - Chairman, President and CEO Jerry Barbato - CFO Xiuming Shum - EVP, Legal and Regulatory Affairs Conference Call Participants Ta...
Cronos Group ( CRON -7.7% ) Q2 results : More news on: Cronos Group Inc., Healthcare stocks news, Earnings news and commentary, Read more ...
Cronos Group (NASDAQ: CRON ) : Q2 GAAP EPS of -$0.31 misses by $0.24 . More news on: Cronos Group Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Cronos Israel commenced the sale of PEACE NATURALS™ products to the Israeli medical cannabis market Natuera completed three additional test exports of hemp-derived CBD extract to the U.S. for business development and R&D purposes Successfully implemented a new ente...
It's hard to put a price tag on the value of a brand. Forged over decades (or even generations), a company's brand can make the difference between surviving through difficult times or going under. Here are two value stocks that are trading at bargain prices due to the coronavirus pandemic a...
News, Short Squeeze, Breakout and More Instantly...
A recent study highlights that more than 20% of patients visiting orthopedic surgeons for chronic musculoskeletal (MSK) pain have turned to marijuana for relief . Among these individuals, nearly two-thirds found marijuana to be somewhat effective, and more than 90% reported at least slight effec...
TORONTO, July 25, 2024 (GLOBE NEWSWIRE) -- Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2024 second quarter earnings conference call on Thursday, August 8, 2024 at 8:30 a.m. ET. Cronos’ senior management team will discus...